In Brief: Endo Labs
Executive Summary
Endo Labs: Relisting of Somerset's Eldepryl (selegiline) 5 mg tablets in the "Orange Book" requested by the DuPont Merck generics subsidiary in June 14 citizen petition. Somerset withdrew Eldepryl tablets from market after it gained approval on May 17 for a 5 mg capsule formulation of the Parkinson's treatment. The orphan exclusivity for selegiline tablets expired June 5...